CA
NZ
UK
AU
IND
US
RB Global, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting condensed consolidated financial results for the three and nine months ended that date.
Turn Therapeutics Inc. filed a Form S-3 registration statement with the SEC on November 9, 2026, covering the potential offering of up to $150,000,000 in aggregate securities and including a separate at-the-market facility of up to $50,000,000 in common stock through TD Securities (USA) …
Superior Group of Companies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with NASDAQ:SGC on November 9, 2026, reporting third-quarter net sales of $145,994 thousand and nine-month net sales of $434,708 thousand.
Spruce Biosciences, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, disclosing a going concern doubt and a range of material operational risks.
Ocular Therapeutix, Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 9, 2026, to register an additional 1,000,000 shares of common stock issuable under its 2019 Inducement Stock Incentive Plan, as amended.
Wearable Devices Ltd. Executive Vice President of Business Development Remez Offir filed a Form 4 on November 9, 2026, disclosing the acquisition of 20,000 Restricted Share Units on November 5, 2026, at a price of $0.
Michael Exton, Chief Executive Officer and Director of Lexicon Pharmaceuticals, Inc., filed a Form 4 on November 9, 2026, disclosing an open-market purchase of common stock on November 6, 2026.
Oppenheimer Holdings Inc. filed an 8-K on November 9, 2026, announcing that its subsidiary Oppenheimer & Co. Inc. plans to relocate its headquarters to 32 Old Slip in Lower Manhattan, with a phased move-in targeted to begin in the first quarter of 2028.
Biomolecular Life Holdings, Inc. filed an 8-K on November 9, 2026, announcing an agreement to acquire land in Llanogrande, Rionegro, Antioquia, Colombia, for a planned Biomolecular Wellness Spa and Longevity Retreat in an all-stock related-party transaction.
Sirius XM Holdings Inc. filed a Form 8-K on November 9, 2026, disclosing the appointment of Anjali Sud as Chief Executive Officer effective January 1, 2027, and the departure of Jennifer C. Witz from that role and from the board effective December 31, 2026.
Please wait processing your request...